Skip to main content

It looks like you are visiting from outside the EU. Switch to the US version to see local pricing in USD and local shipping.

Switch to US ($)

Get 25% off your first bioreagent online order — use code: PROTEOSHOP25

📢 New ! Accelerate your Antibody Development with Ready-to-use Stable Cell Pools

Explore Now
Brand: ProteoGenix

Ocaratuzumab Biosimilar – Anti-MS4A1, CD20 mAb – Research Grade

Clonality:
Monoclonal Antibody
Isotype:
IgG1, kappa

200.00

100ug + 200 loyalty points
Size
  • In Stock
  • Free shipping in EU on orders > €500
  • Wide range of unique reagents
  • Fast worldwide delivery

Ocaratuzumab Biosimilar - Anti-MS4A1, CD20 mAb - Research Grade

Product name Ocaratuzumab Biosimilar - Anti-MS4A1, CD20 mAb - Research Grade
Source CAS 1169956-08-4
Species Humanized
Purity >85%
Buffer PBS buffer PH7.5
Delivery condition Blue ice (+4°C)
Delivery Time 3-5 days if in stock; 3-5 weeks if production needed
Storage condition store at -80°C
Brand ProteoGenix
Applications ELISA,WB
Aliases /Synonyms Ocaratuzumab,AME-133v,LY2469298,MS4A1, CD20,anti-MS4A1, CD20
Reference PX-TA1298
Note For research use only. Not suitable for clinical or therapeutic use.
Isotype IgG1-kappa
Clonality Monoclonal Antibody
Product name Ocaratuzumab Biosimilar - Anti-MS4A1, CD20 mAb - Research Grade
Source CAS 1169956-08-4
Species Humanized
Expression system Mammalian cells
Purity >85%
Buffer PBS buffer PH7.5
Delivery condition Blue ice (+4°C)
Delivery Time 3-5 days if in stock; 3-5 weeks if production needed
Storage condition store at -80°C
Brand ProteoGenix
Applications ELISA,WB,,,
Aliases /Synonyms Ocaratuzumab,AME-133v,LY2469298,MS4A1, CD20,anti-MS4A1, CD20
Reference PX-TA1298
Note For research use only. Not suitable for clinical or therapeutic use.
Isotype IgG1-kappa
Clonality Monoclonal Antibody

General information on Anti-MS4A1/CD20[Homo sapiens] (Ocaratuzumab) Monoclonal Antibody

Ocaratuzumab is used for the treatment of cancer and autoimmune disorders. The antibody has been designed with an increased affinity to the CD20 antigen on B-lymphocytes, to enhance antibody-dependent cell-mediated cytotoxicity (ADCC).

Ocaratuzumab Biosimilar - Anti-MS4A1, CD20 mAb binds to Human CD20/MS4A1 recombinant protein in indirect ELISA Assay

Ocaratuzumab Biosimilar - Anti-MS4A1, CD20 mAb binds to Human CD20/MS4A1 recombinant protein in indirect ELISA Assay

Immobilized Human CD20/MS4A1 recombinant protein (cat. No.PX-P6274) at 0.5µg/mL (100µL/well) can bind to Ocaratuzumab Biosimilar - Anti-MS4A1, CD20 mAb (cat. No.PX-TA1298) in indirect ELISA with Goat Anti-Human IgG secondary antibody coupled with HRP measured by OD450

There are no reviews yet.

Be the first to review “Ocaratuzumab Biosimilar – Anti-MS4A1, CD20 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Recently viewed products

Loading recently viewed products…

Can’t find what you need?

Our catalog doesn’t cover everything — but our team does. Whether you need a custom antibody, a specific protein variant, or a bulk order, our scientists are here to help.

Contact Our Team Book a Call

Cart (0 Items)

Your cart is currently empty.

View Products